Crossmark

Clinical efficacy and safety of arbekacin for high-risk infections in patients with hematological malignancies

Crossref DOI link: https://doi.org/10.1007/s12185-015-1926-6

Published Online: 2015-12-29

Published Print: 2016-03

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Miura, Katsuhiro

Nakagawa, Masaru

Takahashi, Hiromichi

Uchino, Yoshihito

Kodaira, Hitomi

Iriyama, Noriyoshi

Sakagami, Masashi

Ohtake, Shimon

Kobayashi, Sumiko

Hojo, Atsuko

Kurita, Daisuke

Kobayashi, Yujin

Kusuda, Machiko

Hirabayashi, Yukio

Hatta, Yoshihiro

Takei, Masami
License Information

Text and Data Mining valid from 2015-12-29